Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 4/20 | 0.58 |
| ▸ | HTR2A | P28223 | 2/20 | 0.45 |
| ▸ | RET | P07949 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29415502 | 1.00 | IDO1 (0.58) | IDO1HTR2ARETTSHRADRA2A | |
| SCHEMBL40422 | 1.00 | IDO1 (0.58) | IDO1HTR2ARETTSHRADRA2A | |
| SCHEMBL30837489 | 1.00 | IDO1 (0.58) | IDO1HTR2ARETTSHRADRA2A | |
| SCHEMBL14543304 | 1.00 | IDO1 (0.58) | IDO1HTR2ARETTSHRADRA2A | |
| SCHEMBL10774751 | 1.00 | IDO1 (0.58) | IDO1HTR2ARETTSHRADRA2A | |
| SCHEMBL44600 | 1.00 | IDO1 (0.58) | IDO1HTR2ARETTSHRADRA2A | |
| Bromide SCHEMBL3727459 | 0.98 | IDO1 (0.56) | IDO1HTR2ARETADRA2AADRA1A | |
| Methane SCHEMBL9503230 | 0.98 | IDO1 (0.56) | IDO1HTR2ARETADRA2AADRA1A | |
| Hydrochloric Acid SCHEMBL7424398 | 0.98 | IDO1 (0.59) | IDO1HTR2ARET | |
| Hydrochloric Acid SCHEMBL29757860 | 0.98 | IDO1 (0.59) | IDO1HTR2ARET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 829 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120152488-A | Self-driven X-ray detector based on metal cation doped chiral perovskite and preparation method thereof | 郑州大学 | 2025-06-13 | — | — | CN | claimed |
| CN-119899184-A | Beta-carboline compound, preparation method thereof and application thereof in resisting Alzheimer disease | 中国人民解放军北部战区总医院 | 2025-04-29 | — | — | CN | claimed |
| US-20250078176-A1 | ENVIRONMENTAL ATTRIBUTES FOR NITROGEN CONTAINING CHEMICALS | BASF SE (DE) | 2025-03-06 | — | — | US | claimed |
| CN-119490460-A | Preparation method of IDH1 mutant inhibitor | 昆药集团股份有限公司 | 2025-02-21 | — | — | CN | claimed |
| US-12104106-B2 | Compositions of chiral molecules and perovskite nanocrystals and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2024-10-01 | — | — | US | claimed |
| CN-118684616-A | Polymer composite material with circularly polarized room temperature phosphorescence characteristic and preparation method and application thereof | 衡阳爱洁科技股份有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-118599796-A | Lysine amine dehydrogenase mutant and application thereof in chiral amine compound synthesis | 山东大学 | 2024-09-06 | — | — | CN | claimed |
| CN-116790686-A | Method for synthesizing (R) -2- (1-aminoethyl) -4-fluorophenol by biological enzyme method | 中国科学院青岛生物能源与过程研究所 | 2023-09-22 | — | — | CN | claimed |
| WO-2023117926-A1 | ENVIRONMENTAL ATTRIBUTES FOR NITROGEN CONTAINING CHEMICALS | BASF SE (DE) | 2023-06-29 | — | — | WO | claimed |
| US-20220326082-A1 | CHIRAL HETEROSTRUCTURES | Alliance for Energy Innovation, LLC | 2022-10-13 | — | — | US | claimed |
| WO-2013108227-A1 | HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2013-07-25 | — | — | WO | claimed |
| CN-102675123-A | Resolving and racemization method for 1-amino-1,2,3,4-tetrahydronaphthalene | SHANGHAI LANGTZE BIOMEDICAL TECHNOLOGY CO LTD | 2012-09-19 | — | — | CN | claimed |
| US-8084630-B2 | Process for the synthesis of ramelteon and its intermediates | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2011-12-27 | — | — | US | claimed |
| EP-2098519-A1 | Process for the synthesis of ramelteon and its intermediates | Teva Pharmaceutical Industries Ltd. (IL) | 2009-09-09 | — | — | EP | claimed |
| EP-1874748-B1 | 2 -AMINOCARBONYL SUBSTITUTED PIPERAZINE OR DIAZA-CYCLIC COMPOUNDS AS APOPTOSIS PROTEIN INHIBITOR (IAP) MODULATORS | NOVARTIS AG (CH) | 2009-08-12 | — | — | EP | claimed |
| EP-2069320-A2 | PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES | Teva Pharmaceutical Industries Ltd. (IL) | 2009-06-17 | — | — | EP | claimed |
| US-20090069581-A1 | PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2009-03-12 | — | — | US | claimed |
| WO-2008151170-A2 | PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-12-11 | — | — | WO | claimed |
| WO-2008034032-A2 | BETA-LACTAM CANNABINOID RECEPTOR MODULATORS | AZEVAN PHARMACEUTICALS, INC. (US) | 2008-03-20 | — | — | WO | claimed |
| WO-2007064272-A1 | BENZHYDRYL AMIDE DERIVATIVES AS CANNABINOID RECEPTOR ANTAGONISTS OR INVERSE AGONISTS | ASTRAZENECA AB (SE) | 2007-06-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069581-A1 | PROCESS FOR THE SYNTHESIS OF RAMELTEON AND ITS INTERMEDIATES | CYP2B6, UGT1A6, CYP2A6 | IDO1 2791/4885HTR2A 2028/4885RET 2809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.